뇌질환의 혁신, 뉴로벤티(NeuroVenti)

NEWS

Here's the news about NeuroVenti

BIO KOREA 2020 Invest Fair Neuroventi

페이지 정보

조회 421회 작성일 20-07-01

본문

BIO KOREA 2020 Invest Fair Neuroventi

20-07-01


At the BIO KOREA 2020 Invest Fair, Shin Chan-young, CEO of Neuroventi, introduces autism and the development of therapeutic agents for treatment.

Neuroventi Co., Ltd. was established in 2015 by CEO Chan-Young Shin, and is currently in pre-clinical development to develop a treatment for autism spectrum disorder. do